Mehmet A. Bilen Department of Medical Oncology Winship Cancer Institute of Emory University Biography Publications Institution JoVE Articles Mehmet A. Bilen has not added a biography. If you are Mehmet A. Bilen and would like to personalize this page please email our Author Liaison for assistance. Publications Symptomatic Methemoglobinemia in a Patient with Metastatic Clear Cell Renal Cell Carcinoma Treated with Pembrolizumab and Axitinib Combination Therapy: a Case Report Journal of Medical Case Reports. Feb, 2021 | Pubmed ID: 33602288 Small-Cell Carcinoma of the Prostate: Report of Outcomes of Localized Disease Using the National Cancer Database Clinical Genitourinary Cancer. Jan, 2021 | Pubmed ID: 33582100 Immune Checkpoint Inhibitors in Advanced Upper and Lower Tract Urothelial Carcinoma: a Comparison of Outcomes BJU International. Feb, 2021 | Pubmed ID: 33556233 Successful Recruitment of Black Men to Prostate Cancer Clinical Trials-A Lesson in Achievement JAMA Network Open. 01, 2021 | Pubmed ID: 33496790 A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors European Urology Oncology. Jan, 2021 | Pubmed ID: 33423945 Results of a Multicenter, Phase 2 Study of Nivolumab and Ipilimumab for Patients with Advanced Rare Genitourinary Malignancies Cancer. Mar, 2021 | Pubmed ID: 33216356 Neoadjuvant Cabozantinib in an Unresectable Locally Advanced Renal Cell Carcinoma Patient Leads to Downsizing of Tumor Enabling Surgical Resection: A Case Report Frontiers in Oncology. 2020 | Pubmed ID: 33598435 Immunotherapy in Sarcomatoid Renal Cell Carcinoma: A Case for Optimism Cancer Treatment and Research Communications. 2020 | Pubmed ID: 33307510 Phase 1 Safety and Pharmacodynamic Study of Lenalidomide Combined with Everolimus in Patients with Advanced Solid Malignancies with Efficacy Signal in Adenoid Cystic Carcinoma British Journal of Cancer. 10, 2020 | Pubmed ID: 32704173 Activity of Cabozantinib After Immune Checkpoint Blockade in Metastatic Clear-cell Renal Cell Carcinoma European Journal of Cancer (Oxford, England : 1990). 08, 2020 | Pubmed ID: 32599410 Clinical Impact of COVID-19 on Patients with Cancer (CCC19): a Cohort Study Lancet (London, England). 06, 2020 | Pubmed ID: 32473681 Current Landscape of Immunotherapy in Genitourinary Malignancies Advances in Experimental Medicine and Biology. 2020 | Pubmed ID: 32301013 Dynamic Evaluation of the Modified Glasgow Prognostic Scale in Patients With Resected, Localized Clear Cell Renal Cell Carcinoma Urology. Jul, 2020 | Pubmed ID: 32294483 Novel Risk Group Stratification for Metastatic Urothelial Cancer Patients Treated with Immune Checkpoint Inhibitors Cancer Medicine. 04, 2020 | Pubmed ID: 32100417 Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study The Journal of Urology. 07, 2020 | Pubmed ID: 31971495 Impact of Performance Status on Treatment Outcomes: A Real-world Study of Advanced Urothelial Cancer Treated with Immune Checkpoint Inhibitors Cancer. 03, 2020 | Pubmed ID: 31829450 Multidisciplinary Care of Adult Wilms' Tumor During Pregnancy: A Case Report and Review of the Literature Clinical Genitourinary Cancer. 02, 2020 | Pubmed ID: 31732475 Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors The Oncologist. Dec, 2019 | Pubmed ID: 31806780 Management of Metastatic Renal Cell Carcinoma: The Complexity of Choice EBioMedicine. 09, 2019 | Pubmed ID: 31501075 Sites of Metastasis and Association with Clinical Outcome in Advanced Stage Cancer Patients Treated with Immunotherapy BMC Cancer. Aug, 2019 | Pubmed ID: 31464611 Clinical Outcomes of Advanced Stage Cancer Patients Treated with Sequential Immunotherapy in Phase 1 Clinical Trials Investigational New Drugs. 12, 2019 | Pubmed ID: 30725388 The Prognostic and Predictive Impact of Inflammatory Biomarkers in Patients Who Have Advanced-stage Cancer Treated with Immunotherapy Cancer. 01, 2019 | Pubmed ID: 30329148 Cabozantinib for the Treatment of Patients with Metastatic Non-clear Cell Renal Cell Carcinoma: A Retrospective Analysis European Journal of Cancer (Oxford, England : 1990). 11, 2018 | Pubmed ID: 30380460 Characterization of Metastatic Urothelial Carcinoma Via Comprehensive Genomic Profiling of Circulating Tumor DNA Cancer. May, 2018 | Pubmed ID: 29517810 A Novel Preoperative Inflammatory Marker Prognostic Score in Patients with Localized and Metastatic Renal Cell Carcinoma Asian Journal of Urology. Oct, 2017 | Pubmed ID: 29387555 Recent Developments in the Management of Germ Cell Tumors Current Opinion in Oncology. May, 2017 | Pubmed ID: 28151756 Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos Sean Steele1, Fangyi Lin1, Thien-Linh Le1, Alexandra Medline1, Michelle Higgins1, Alex Sandberg1, Sean Evans1, Gordon Hong2, Milton A. Williams3, Mehmet A. Bilen4, Sarah Psutka5, Kenneth Ogan1, Viraj A. Master1 1Department of Urology, Emory University School of Medicine, 2Northeast Ohio Medical University, 3Department of Urology, University of Alabama at Birmingham, 4Department of Medical Oncology, Winship Cancer Institute of Emory University, 5Department of Urology, University of Washington JoVE 61674 Medicine
Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos Sean Steele1, Fangyi Lin1, Thien-Linh Le1, Alexandra Medline1, Michelle Higgins1, Alex Sandberg1, Sean Evans1, Gordon Hong2, Milton A. Williams3, Mehmet A. Bilen4, Sarah Psutka5, Kenneth Ogan1, Viraj A. Master1 1Department of Urology, Emory University School of Medicine, 2Northeast Ohio Medical University, 3Department of Urology, University of Alabama at Birmingham, 4Department of Medical Oncology, Winship Cancer Institute of Emory University, 5Department of Urology, University of Washington JoVE 61674 Medicine
